Detalhe da pesquisa
1.
Novel influenza A(H1N2) seasonal reassortant identified in a patient sample, Sweden, January 2019.
Euro Surveill
; 24(9)2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862332
2.
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Influenza Other Respir Viruses
; 18(1): e13243, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38204584